Investors in Ev

Gap Minder is a 45 Mil $ Venture Capital Fund targeting IT Software and Services start-ups in Romania and Central Eastern Europe. We sit at the heart of the fastest growing European economy with a distinctive technological ecosystem being the third global market for quality and speed of Internet connectivity. In a dynamic and growing start-up ecosystem, we are committed to support passionate and thoughtful founders to become global entrepreneurs and to rewrite the place of Romania and Central Eastern Europe in the global tech arena. Innovation, People, Impact. These are the 3 pillars of our investment vision. We are growing disruptive technologies, daring ideas and strong leaders and we value creativity, value creation and the potential of the businesses to impact markets. We are creating a major hub for innovation and entrepreneurship for Romania which will help us positioning among the leaders in European Innovation.

At Lightbird, we partner, early in the journey, with companies that lead with distribution. We believe that establishing this from the beginning is the only way to stand out in today’s market.

Creathor Ventures invests in technology-oriented companies that drive the automation of industry and business, and the personalization and digitalization of healthcare. The regional focus is on Germany and Switzerland. From its locations in Bad Homburg and Zurich, the team currently supports over 30 tech and healthcare companies. Over the past 30 years, the management team has financed over 200 companies as lead or co-lead investors. More than 20 companies have been listed on international stock exchanges. Creathor Ventures currently manages a fund volume of over 230 million euros.

Freya Capital is a venture capital fund supporting and financing innovative businesses making an impact on tomorrow’s world. We invest up to EUR 1 million in early-stage companies with high growth potential and international scaling ambitions.

Generali Ventures is underway: with a dedicated commitment of €250 million, we aim to identify and invest in high-growth opportunities, particularly in the insurtech and fintech sectors. Generali Ventures is more than just a venture capital initiative: it is a testament to our commitment to innovation and our drive to transform the insurance sector. We are dedicated to staying at the forefront of emerging technologies and providing our customers with the best possible service. The initiative was designed to address challenges arising from the sector’s rapid evolution, evolving customer needs and significant global trends.

J&T Ventures is an early-stage Prague based Venture Capital fund, which invests into promising startups from the CEE and SEE region. Our strategy is industry agnostic, but we primarily focus on companies in seed stage with proven product market fit. Our average ticket size is between 0.5m EUR - 3m EUR.

Radix is a new Venture Capital Fund established by experienced investors and technology entrepreneurs based in Central and Eastern Europe with the mission to empower radical innovations.

We lead ambitious seed rounds. New Wave is a seed only fund, whose purpose is to back the next generation of successful European founders. New Wave was co-founded by two early-stage investors Pia d'Iribarne (ex-Accel, Stride) and Jean de La Rochebrochard (Kima), and is backed by a group of iconic founders (Free, Zenly, Voodoo, Sorare) and GPs from the best later-stage funds(Coatue, Benchmark, DST, Insight Partners).

Founded by athletes, for athletes. We invest in the next generation of tech enabled startups at Seed & Series A. We implement an investment strategy that harnesses the privileged access to private deals afforded to elite professional athletes. We then add tangible growth by leveraging our network for early-stage companies. We are generalist Seed and Series A investors, writing initial cheques of £50,000 to £300,000 into high-performing early-stage businesses. We focus predominantly on the UK and Europe, but we remain open to exceptional global opportunities. We are not lead investors – instead, we co-invest alongside world-class VCs, collaborating on opportunities with market leading investors and founders.

Fountain Healthcare Partners is a life science venture capital firm based in Dublin Ireland with an office in New York. Fountain currently manages over €300M and is actively investing its third fund raised in 2019. The team at Fountain originally worked within the corporate VC group at Elan Corporation and raised its first independent fund in 2008. Fountain invests in drugs, devices and diagnostics with a focus on companies developing innovative products that address unmet medical needs and deliver significant pharmacoeconomic benefits.

The Joint Polish Investment Fund, ("JPIF") is a new Life Science Venture Capital Fund, which focuses on investments in Life Science companies with visible and near-term value inflection points and a prospective holding period of 3-5 years. JPIF consists of a team of people with broad experience in the life-science sector. Scientists and medical doctors with industrial experience work hand in glove with colleagues who have a thorough training in economics and business affairs. Everybody is driven by true interest in the life science field and new technologies, which will greatly contribute to people’s health disease management and quality of life. Entrepreneurs backed by JPIF have access to the knowledge and advice of each member of the JPIF team and to the associated global scientific and commercial network. Together JPIF and entrepreneurs are therefore in the position to accelerate preclinical, clinical or commercial development and a successful market entry into the most important healthcare markets: Europe, the U.S., and Asia.